Cell Suspension Autograft CPT Coding Recommendation
From Sept. 28:
The ABA Coding Committee has developed the following to provide CPT coding guidance for cases using cell suspension autografts. The Food and Drug Administration (FDA) granted approval on 9/20/18 to market Avita Medical’s RECELL® Autologous Cell Harvesting Device (RECELL) which provides a cell suspension technique to produce Regenerative Epidermal Suspension™ (RES™). This technique provides a type of epidermal autograft that is indicated for the treatment of acute thermal burn injuries to achieve epidermal regeneration and definitive wound closure with sparing use of donor skin.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063